1. Home
  2. DCTH vs TLS Comparison

DCTH vs TLS Comparison

Compare DCTH & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • TLS
  • Stock Information
  • Founded
  • DCTH 1988
  • TLS 1969
  • Country
  • DCTH United States
  • TLS United States
  • Employees
  • DCTH N/A
  • TLS N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • TLS EDP Services
  • Sector
  • DCTH Health Care
  • TLS Technology
  • Exchange
  • DCTH Nasdaq
  • TLS Nasdaq
  • Market Cap
  • DCTH 379.8M
  • TLS 246.1M
  • IPO Year
  • DCTH N/A
  • TLS 2020
  • Fundamental
  • Price
  • DCTH $11.86
  • TLS $3.31
  • Analyst Decision
  • DCTH Strong Buy
  • TLS Buy
  • Analyst Count
  • DCTH 4
  • TLS 6
  • Target Price
  • DCTH $21.50
  • TLS $4.80
  • AVG Volume (30 Days)
  • DCTH 493.6K
  • TLS 879.4K
  • Earning Date
  • DCTH 11-08-2024
  • TLS 11-12-2024
  • Dividend Yield
  • DCTH N/A
  • TLS N/A
  • EPS Growth
  • DCTH N/A
  • TLS N/A
  • EPS
  • DCTH N/A
  • TLS N/A
  • Revenue
  • DCTH $22,644,000.00
  • TLS $122,959,000.00
  • Revenue This Year
  • DCTH $1,605.13
  • TLS N/A
  • Revenue Next Year
  • DCTH $111.67
  • TLS $38.31
  • P/E Ratio
  • DCTH N/A
  • TLS N/A
  • Revenue Growth
  • DCTH 945.91
  • TLS N/A
  • 52 Week Low
  • DCTH $2.60
  • TLS $1.89
  • 52 Week High
  • DCTH $12.88
  • TLS $5.03
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 63.26
  • TLS 43.10
  • Support Level
  • DCTH $9.33
  • TLS $3.10
  • Resistance Level
  • DCTH $12.79
  • TLS $3.48
  • Average True Range (ATR)
  • DCTH 0.65
  • TLS 0.17
  • MACD
  • DCTH 0.24
  • TLS -0.02
  • Stochastic Oscillator
  • DCTH 76.28
  • TLS 24.71

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: